SAGES Magazine

GASTROENTEROLOGY South African EDITORS: Prof A Mahomed Prof M Sonderup Prof S Thomson EDITORIAL REVIEWS • Oesophageal cancer in Sub-Saharan Africa: a Kenyan perspective • Oesophageal stenting: where have we come from and where are we going? CASE SERIES • Solutions from a potpourri of obscure overt GI bleeds CASE REPORT • Multi-level small bowel obstruction due to type 3 idiopathic sclerosing encapsulating peritonitis (SEP) in a young male patient OPINION • The future of congresses for health professionals: changing perspectives GASTROENTEROLOGY FOUNDATION • Using technology to bring the Patient Blood Management (PBM) stakeholders together: 3rd Annual Sub-Saharan PBM Interest Group meeting – Cape Town, 2021 IN REMEMBRANCE • In remembrance of Mike Kew: a remarkable academic SAGES • SAGES Virtual Congress Free Paper Prizes • SAGES Virtual Conference abstracts Review Volume 19, Issue 2, 2021 www.ihpublishing.co.za The official Journal of the South African Gastroenterology Society ISSN - 1812 - 1659 For further product information contact PHARMA DYNAMICS CUSTOMER CARE LINE 0860 PHARMA (742 762)/+27 21 707 7000 www.pharmadynamics.co.za Low Potential Drug Interaction 1 24 Hour Acid Suppression 2 Faster Onset Of Action 2 PEPLOC 20, 40 mg. Each tablet contains pantoprazole sodium sesquihydrate equivalent to Pantoprazole 20, 40 mg respectively. S4 A42/11.4.3/0056, 0057 NAM NS2 10/11.4.3/0473, 0474.1.Wedemeyer RS, et al. Pharmacokinetic Drug Interaction Profiles of PPIs: An Update. Drug Saf 2014;37"201-211. 2.Orr WC. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. European Journal of Gastroenterology & Hepatology. 2005; 17: 113-120. For full prescribing information, refer to the professional information approved by SAHPRA, March 2010. PCA521/01/2020. C M Y CM MY CY CMY K SA Gastro PEPLOC OFC Apr2020.pdf 1 2020/04/30 13:57